Statistical power and analysis
NASH, diabetes
SECONDARY, DIABETES
Because NW has not been studied in patients with NASH, sample size estimates were derived from previous Noom mHealth interventions in patients with diabetes.The analyses included all patients who were randomized. The analyses of the primary end point were performed with the use of both between-group comparisons (2-sample The secondary clinical end points are presented as means with SD. Both between-group and within-group comparisons were performed. Categorical end points were analyzed with chi-squared and Fisher’s exact test where appropriate. Using similar statistical methods, clinically important subgroup analyses were performed to compare NW responders who lost clinically significant body weight (≥5%) to those who did not.